SCHEMBL14155705

SCHEMBL14155705

NCOCC1CCC(F)(F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18231224 0.78 CYP2D6 (0.32)
SCHEMBL21757438 0.78
SCHEMBL21757396 0.74
SCHEMBL102863 0.74 NCF1 (0.39)
SCHEMBL14359726 0.73 SCN9A (0.34)
SCHEMBL17677236 0.72 JAK2 (0.36)
Hydrochloric Acid SCHEMBL306682 0.72 NCF1 (0.37)
Hydrochloric Acid SCHEMBL16033739 0.70 NCF1 (0.36)
SCHEMBL19555539 0.70 CHRM2 (0.37)
SCHEMBL16866836 0.70 SCN9A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077103-A1 PREPERATION AND UTILITY OF CCR5 INHIBITORS AUSPEX PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed